Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ DNA ±â¹Ý ¾Ö¿Ïµ¿¹° ¿µ¾ç ½ÃÀåÀº 2025³â¿¡ 4¾ï 5,328¸¸ ´Þ·¯¸¦ Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ Áß 12.2%ÀÇ CAGR·Î ¼ºÀåÇϸç, 2032³â±îÁö 10¾ï 1,466¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.
DNA ±â¹Ý ¹Ý·Áµ¿¹° ¿µ¾çÀº ¹Ý·Áµ¿¹°ÀÇ °íÀ¯ÇÑ DNA ±¸Á¶¸¦ Æò°¡Çϱâ À§ÇØ À¯ÀüÀÚ ºÐ¼®À» ¼öÇàÇÏ´Â ¸ÂÃãÇü ½Ä´Ü Àü·«ÀÔ´Ï´Ù. À¯ÀüÀû Ư¼º, ½ÄÀÌ ºÒ³»¼º, ´ë»ç ±â´É, °Ç° ¹Î°¨µµ¸¦ ÆÄ¾ÇÇÏ¿© Ưº°ÇÑ ¿µ¾ç °èȹÀ» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ¼öÀÇ»ç¿Í º¸È£ÀÚ´Â Á¤È®ÇÑ ¿µ¾ç Áö¿øÀ» Á¦°øÇϰí, ´õ ³ªÀº ¼Òȸ¦ ÃËÁøÇϰí, Áúº´ À§ÇèÀ» ÁÙÀ̰í, ¹Ý·Áµ¿¹°ÀÇ Àü¹ÝÀûÀÎ °Ç°, ¼ö¸í ¹× »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.
¹Ý·Áµ¿¹°ÀÇ Àΰ£È ¹× ¸ÂÃã ¿µ¾ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
¹Ý·Áµ¿¹°ÀÌ Á¡Á¡ ´õ Áß¿äÇÑ °¡Á· ±¸¼º¿øÀ¸·Î ÀÚ¸® ÀâÀ¸¸é¼ º¸È£ÀÚµéÀº °³º°ÀûÀÎ °ü¸®¸¦ ÅëÇØ ¹Ý·Áµ¿¹°ÀÇ °Ç°°ú ÇູÀ» ¿ì¼±½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È·Î ÀÎÇØ°³ ǰÁ¾º° ÇÊ¿ä¿Í À¯ÀüÀû ¼ÒÀο¡ ¸Â´Â DNA ±â¹Ý ¿µ¾ç °èȹ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀº ¾Ë·¹¸£±â, üÁß°ü¸®, ¸¸¼ºÁúȯ¿¡ ´ëÀÀÇÏ´Â ¸ÂÃãÇü ½Ä´ÜÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ÇÁ¸®¹Ì¾ö ¾Ö¿Ïµ¿¹° »ç·á ºê·£µå¿Í À£´Ï½º Ç÷§ÆûÀÇ µîÀåÀº ÀÌ·¯ÇÑ ÁøÈÇÏ´Â »ç°í¹æ½ÄÀ» ¹Ý¿µÇÕ´Ï´Ù. µðÁöÅÐ Åø¿Í ¸ð¹ÙÀÏ ¾ÛÀº ¹Ý·Áµ¿¹° º¸È£ÀÚ¿¡°Ô ¸ÂÃãÇü ¿µ¾ç °ü¸®¸¦ ´õ¿í Ä£¼÷ÇÏ°í ¸Å·ÂÀûÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î Àΰ£°ú ¹Ý·Áµ¿¹° »çÀÌÀÇ Á¤¼Àû À¯´ë°¨ÀÌ °úÇÐÀû ±Ù°Å°¡ ÀÖ´Â ¸ÂÃãÇü ½Ä´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
DNA °Ë»ç ¹× ¸ÂÃãÇü ¿µ¾ç °èȹ¿¡ µå´Â °í°¡ÀÇ ºñ¿ë
¸¹Àº ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀº À¯ÀüÀÚ Å°Æ®¿Í Áö¼ÓÀûÀÎ Á¤¾×Á¦ ¿µ¾ç ¼ºñ½º¿¡ µå´Â Ãʱ⠺ñ¿ë¿¡ ´ëÇØ °í¹ÎÇϰí ÀÖ½À´Ï´Ù. º¸Çè Àû¿ë ¹üÀ§°¡ Á¦ÇÑÀûÀÌ°í »óȯ ¿É¼ÇÀÌ ¾ø½À´Ï´Ù´Â Á¡ÀÌ ½ÃÀå ħÅõ¸¦ ´õ¿í Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï ±¹°¡¿¡¼´Â °æÁ¦ÀûÀÎ ¹®Á¦°¡ ´õ µÎµå·¯Á® º¸±ÞÀÌ ´Ê¾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼öÀÇ»ç ÁøÂûÀÇ Çʿ伺ÀÌ ÃÑ ºñ¿ë¿¡ Ãß°¡µÇ¹Ç·Î ¿¹»êÀ» Áß½ÃÇÏ´Â ¼ÒºñÀÚ¿¡°Ô´Â ½ÇÇà °¡´É¼ºÀÌ ³·½À´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦Àû Á¦¾àÀº È®À强À» ÀúÇØÇÏ°í °í±Þ ¿µ¾ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Á¦ÇÑÇÕ´Ï´Ù.
°í±Þ ¿µ¾çÇÐÀû ÀλçÀÌÆ®¸¦ À§ÇÑ AI¿Í ºòµ¥ÀÌÅÍÀÇ ÅëÇÕ
AI¿Í µ¥ÀÌÅÍ ºÐ¼®ÀÇ ±â¼ú ¹ßÀüÀº ¹Ý·Áµ¿¹°ÀÇ ¿µ¾çÇп¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¾Ë°í¸®ÁòÀº ÇöÀç À¯ÀüÀÚ ¸¶Ä¿, ¶óÀÌÇÁ½ºÅ¸ÀÏ ÀÔ·Â, °Ç° µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© Ãʰ³ÀÎÈµÈ ½Ä´Ü °èȹÀ» »ý¼º ÇÒ ¼ö ÀÖ½À´Ï´Ù. °¢ Ç÷§ÆûÀº ¸Ó½Å·¯´×À» Ȱ¿ëÇÏ¿© ¹Ý·Áµ¿¹°ÀÇ Çൿ°ú Çǵå¹é ·çÇÁ¸¦ ±â¹ÝÀ¸·Î Áö¼ÓÀûÀ¸·Î ÃßõÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â±â ¹× ½º¸¶Æ® ÇÇ´õ¿ÍÀÇ ÅëÇÕÀ» ÅëÇØ ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× ÀûÀÀÇü ¿µ¾ç ¼·Ãë°¡ °¡´ÉÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛÀ» ÅëÇØ ¿øÈ°ÇÑ ¾÷µ¥ÀÌÆ®¿Í ¼öÀÇ»ç Àü¹®°¡¿ÍÀÇ ¿ø°Ý »ó´ãÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀ» ÅëÇØ ¹Ý·Áµ¿¹°ÀÇ °Ç° °á°ú¿Í »ç¿ëÀÚ °æÇèÀ» Çâ»ó½ÃŰ´Â È®Àå °¡´ÉÇÑ µ¥ÀÌÅͺ£À̽º ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.
ºÎÁ¤È®Çϰųª ¿ÀÇØÀÇ ¼ÒÁö°¡ ÀÖ´Â À¯ÀüÀÚ °Ë»ç °á°úÀÇ À§Ç輺
¹Ý·Áµ¿¹° DNA °Ë»çÀÇ ½Å·Ú¼ºÀº °Ë»ç±â°ü¿¡ µû¶ó Å©°Ô Â÷À̰¡ ³ª±â ¶§¹®¿¡ µ¥ÀÌÅÍÀÇ Á¤È®¼º¿¡ ´ëÇÑ ¿ì·Á¸¦ ³º°í ÀÖ½À´Ï´Ù. À¯ÀüÀÚ °Ë»ç °á°ú¸¦ À߸ø ÇØ¼®ÇÏ¸é ºÎÀûÀýÇÑ ½Ä´Ü ¼±Åðú °Ç° À§ÇèÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. Ç¥ÁØÈµÈ °Ë»ç ÇÁ·ÎÅäÄݰú ±ÔÁ¦ °¨µ¶ÀÇ ºÎÀç°¡ ÀÌ ¹®Á¦¸¦ ´õ¿í ¾ÇȽÃ۰í ÀÖ½À´Ï´Ù. ÃæºÐÇÑ °úÇÐÀû °ËÁõ ¾øÀÌ °á°ú¸¦ °úµµÇÏ°Ô ¾à¼ÓÇÏ´Â Ç÷§Æûµµ ÀÖÀ¸¸ç, ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ ¶³¾î¶ß¸³´Ï´Ù. ǰÁ¾ ½Äº°À̳ª °Ç° ¼ÒÀÎÀÇ ¿À·ù´Â À߸øµÈ °³ÀÔÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À§ÇùÀº DNA ±â¹Ý ¿µ¾ç ¼ºñ½º¿¡¼ ¾ö°ÝÇÑ °ËÁõ, Åõ¸í¼º, Àü¹®°¡ ÁöµµÀÇ Çʿ伺À» °Á¶Çϰí ÀÖ½À´Ï´Ù.
COVID-19ÀÇ ¿µÇâ
ÆÒµ¥¹ÍÀº ¹Ý·Áµ¿¹° ¾çÀ°À» °¡¼ÓÈÇϰí, Á¤¼Àû À¯´ë°¨À» °ÈÇϸç, ¹Ý·Áµ¿¹°ÀÇ °Ç°¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇß½À´Ï´Ù. ·Ï´Ù¿îÀ¸·Î ÀÎÇØ °³ÀÎÈµÈ ¹Ý·Áµ¿¹° »ç·á¿Í DNA ŰƮÀÇ ¿Â¶óÀÎ ±¸¸Å°¡ Áõ°¡Çß½À´Ï´Ù. °ø±Þ¸ÁÀÇ È¥¶õÀ¸·Î ÀÎÇØ ÀϽÃÀûÀ¸·Î Á¦Ç° Àç°í »óȲ°ú ³³±â¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¿ø°Ý ÄÁ¼³ÆÃ°ú Á¤±â ±¸¸ÅÇü ¿µ¾ç ¼ºñ½º¸¦ Á¦°øÇÏ´Â µðÁöÅÐ Ç÷§ÆûÀÌ È®»êµÇ°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ È¸º¹·Â ÀÖ°í ¹Ì·¡ÁöÇâÀûÀÎ ÄÉ¾î ¸ðµ¨À» Ãß±¸ÇÏ´Â °¡¿îµ¥, DNA ±â¹Ý ¿µ¾çÀº ÆÒµ¥¹Í ÀÌÈÄ ¹Ý·Áµ¿¹° °Ç°ÀÇ Áß¿äÇÑ ÃàÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ Áß °³º°ÈµÈ ¹Ý·Áµ¿¹° ½Ä»ç °èȹ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
°³º°ÈµÈ ¹Ý·Áµ¿¹° ½Ä»ç °èȹ ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀº ¾Ë·¹¸£±â, ¼Òȱâ Áúȯ, üÁß °ü¸® µî¿¡ ´ëÀÀÇÏ´Â ¸ÂÃãÇü »ç·á¸¦ ¼±ÅÃÇÏ´Â °æÇâÀÌ °ÇØÁö°í ÀÖ½À´Ï´Ù. ±¸µ¶ ¸ðµ¨°ú ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å Ç÷§ÆûÀº ¸ÂÃãÇü ¿µ¾ç¿¡ ´ëÇÑ Á¢±ÙÀ» ´Ü¼øÈÇϰí ÀÖ½À´Ï´Ù. ¿ø·á Á¶´Þ°ú ¹èÇÕÀÇ ¹ßÀüÀ¸·Î Á¦Ç°ÀÇ Ç°Áú°ú È¿´ÉÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. À¯ÀüÀû ÀλçÀÌÆ®¸¦ ½Ä´Ü °èȹ¿¡ ÅëÇÕÇÏ´Â °ÍÀº Ç¥ÁØ ±â´ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. °³ÀÎȰ¡ ÁÖ·ù·Î ÀÚ¸® ÀâÀ¸¸é¼ ÀÌ ºÎ¹®Àº DNA ±â¹Ý ¹Ý·Áµ¿¹° ¿µ¾çÁ¦ ½ÃÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¹Ý·Áµ¿¹° À£´Ï½º ½ºÅ¸Æ®¾÷ ¹× Ç÷§Æû ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¿¹Ãø ±â°£ Áß ¹Ý·Áµ¿¹° À£´Ï½º ½ºÅ¸Æ®¾÷ ¹× Ç÷§Æû ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Çõ½Å¿¡´Â ¸ð¹ÙÀÏ ¾Û, AI¸¦ Ȱ¿ëÇÑ Áø´Ü, ±¸µ¶Çü DNA °Ë»ç ŰƮ µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¹Îø¼ºÀº ¼ÒºñÀÚÀÇ ÃëÇâ°ú »õ·Î¿î µ¿Çâ¿¡ ºü¸£°Ô ÀûÀÀÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. µ¿¹°º´¿ø ³×Æ®¿öÅ© ¹× E-Commerce Ç÷§Æû°úÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ µµ´Þ ¹üÀ§¸¦ ³ÐÇô°¡°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ÀüÀÎÀû Ä¡·á¿Í ¿¹¹æ ÀǷḦ ¹Þ¾ÆµéÀÌ¸é¼ À̵é Ç÷§ÆûÀº ºñ¾àÀûÀÎ ¼ºÀåÀ» Çϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¹Ý·Áµ¿¹° »çÀ° Áõ°¡¿Í µµ½ÃÈ·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í ¹Ý·Áµ¿¹°ÀÇ °Ç°¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÇÁ¸®¹Ì¾ö ¸ÂÃãÇü ¿µ¾ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. E-CommerceÀÇ ¼ºÀå°ú ¸ð¹ÙÀÏ ¿ì¼±ÀÇ ¼ÒºñÀÚ ÇൿÀº µðÁöÅÐ À£´Ï½º Ç÷§ÆûÀÇ Ã¤ÅÃÀ» °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù. Áö¿ª ±â¾÷Àº Áö¿ª Æ¯È Á¦Á¦ ¹× ǰÁ¾º° ¼Ö·ç¼Ç¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. µ¿¹° º¹Áö¿Í ¼öÀÇÇÐ ÀÎÇÁ¶ó¸¦ ÃËÁøÇÏ´Â Á¤ºÎÀÇ ±¸»óÀÌ ½ÃÀå È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ Áß ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, °í±Þ ¼öÀÇÇÐ ¼ºñ½º ¹× ±â¼ú¿¡ Á¤ÅëÇÑ ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚÀÇ ÁöÁö¸¦ ¹ÞÀ» °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯ÀüÀÚ °Ë»ç¿Í ¸ÂÃãÇü ¿µ¾ç Ç÷§ÆûÀÇ ³ôÀº º¸±Þ·üÀº ºü¸¥ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á, ½º¸¶Æ® ÇÇ´õ, AI ±â¹Ý Áø´Ü µîÀÇ µ¿ÇâÀÌ ¾Ö¿Ïµ¿¹° ÄɾîÀÇ ±Ô¹üÀ» À籸¼ºÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦°¡ ¸íÈ®ÇØÁö°í °úÇÐÀû ±Ù°Å°¡ ÀÖ´Â Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ½Å·Ú°¡ ³ô¾ÆÁö¸é¼ ½ÃÀå ½Å·Úµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß°ú Á¦Ç° Çõ½Å¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ°¡ °æÀïÀû Â÷º°È¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global DNA-Based Pet Nutrition Market is accounted for $453.28 million in 2025 and is expected to reach $1014.66 million by 2032 growing at a CAGR of 12.2% during the forecast period. DNA-based pet nutrition is a customized dietary strategy that relies on genetic analysis to evaluate a pet's unique DNA structure. Through the identification of genetic traits, dietary intolerances, metabolic functions, and health susceptibilities, it enables the development of specialized nutrition plans. This approach allows veterinarians and pet owners to deliver accurate nutritional support, promoting better digestion, reducing disease risks, and improving pets' overall health, longevity, and quality of life.
Growing pet humanization and demand for personalized nutrition
As pets increasingly become integral family members, owners are prioritizing their health and well-being through personalized care. This shift has led to growing interest in DNA-based nutrition plans that cater to breed-specific needs and genetic predispositions. Consumers are seeking customized diets that address allergies, weight management, and chronic conditions. The rise of premium pet food brands and wellness platforms reflects this evolving mindset. Digital tools and mobile apps are making personalized nutrition more accessible and engaging for pet owners. Overall, the emotional bond between humans and pets is fueling demand for scientifically backed, individualized meal solutions.
High cost of DNA testing and customized nutrition plans
Many pet owners are deterred by the upfront costs of genetic kits and ongoing subscription-based nutrition services. Limited insurance coverage and lack of reimbursement options further restrict market penetration. In emerging economies, affordability challenges are more pronounced, slowing uptake. Additionally, the need for veterinary consultation adds to the total cost, making it less viable for budget-conscious consumers. These financial constraints hinder scalability and limit access to advanced nutritional solutions.
Integration of AI and big data for advanced nutrition insights
Technological advancements in AI and data analytics are revolutionizing the pet nutrition landscape. Algorithms can now analyze genetic markers, lifestyle inputs, and health data to generate hyper-personalized diet plans. Platforms are leveraging machine learning to continuously refine recommendations based on pet behavior and feedback loops. Integration with wearable devices and smart feeders enables real-time monitoring and adaptive nutrition. Cloud-based systems allow seamless updates and remote consultations with veterinary experts. These innovations are unlocking scalable, data-driven solutions that enhance pet health outcomes and user experience.
Risk of inaccurate or misleading genetic test results
The reliability of pet DNA tests varies widely across providers, raising concerns about data accuracy. Misinterpretation of genetic results can lead to inappropriate dietary choices and health risks. Lack of standardized testing protocols and regulatory oversight exacerbates the issue. Some platforms overpromise outcomes without sufficient scientific validation, eroding consumer trust. Errors in breed identification or health predisposition can result in misguided interventions. This threat underscores the need for rigorous validation, transparency, and professional guidance in DNA-based nutrition services.
Covid-19 Impact
The pandemic accelerated pet adoption and deepened emotional bonds, prompting greater investment in pet wellness. Lockdowns led to increased online purchases of personalized pet food and DNA kits. Supply chain disruptions temporarily affected product availability and delivery timelines. Digital platforms offering remote consultations and subscription-based nutrition gained traction. As pet owners seek resilient and proactive care models, DNA-based nutrition is emerging as a key pillar of post-pandemic pet wellness.
The personalized pet meal plans segment is expected to be the largest during the forecast period
The personalized pet meal plans segment is expected to account for the largest market share during the forecast period, driven by rising demand for breed-specific and condition-targeted diets. Owners are increasingly opting for tailored meals that address allergies, digestive issues, and weight management. Subscription models and direct-to-consumer platforms are simplifying access to customized nutrition. Advancements in ingredient sourcing and formulation are enhancing product quality and efficacy. Integration of genetic insights into meal planning is becoming a standard feature. As personalization becomes mainstream, this segment is set to anchor the DNA-based pet nutrition market.
The pet wellness start-ups & platforms segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pet wellness start-ups & platforms segment is predicted to witness the highest growth rate, as these players are disrupting traditional pet care with tech-enabled solutions and data-driven nutrition. Innovations include mobile apps, AI-powered diagnostics, and subscription-based DNA testing kits. Their agility allows rapid adaptation to consumer preferences and emerging trends. Strategic partnerships with veterinary networks and e-commerce platforms are expanding reach. As pet owners embrace holistic and preventive care, these platforms are poised for exponential growth.
During the forecast period, the Asia Pacific region is expected to hold the largest market share fuelled by rising pet ownership and urbanization. Increasing disposable income and awareness of pet health are driving demand for premium and personalized nutrition. E-commerce growth and mobile-first consumer behavior are accelerating adoption of digital wellness platforms. Regional players are investing in localized formulations and breed-specific solutions. Government initiatives promoting animal welfare and veterinary infrastructure are supporting market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, supported by advanced veterinary services and tech-savvy pet owners. High penetration of genetic testing and personalized nutrition platforms is driving rapid adoption. Trends like telehealth, smart feeders, and AI-driven diagnostics are reshaping pet care norms. Regulatory clarity and consumer trust in science-backed products are boosting market confidence. Strategic investments in R&D and product innovation are fueling competitive differentiation.
Key players in the market
Some of the key players profiled in the DNA-Based Pet Nutrition Market include Mars, Inc., ADM, Nestle S.A., Boehringer Ingelheim Animal Health, Colgate-Palmolive Company, Chr. Hansen Holding A/S, The J.M. Smucker Company, BASF SE, General Mills, Inc., IDEXX Laboratories, Inc., Freshpet, Inc., DSM-Firmenich AG, Zoetis Inc., Virbac S.A., and Elanco Animal Health Incorporated.
In June 2025, ADM and PYCO Industries, Inc., announced that they have signed an agreement to launch a joint venture combining their Lubbock, Texas, cottonseed processing capabilities. The new joint venture will be majority-owned by PYCO and governed by a 6-member board with equal representation from ADM and PYCO. ADM and PYCO will each contribute their Lubbock-based processing facilities to the new company.
In August 2024, Mars, Incorporated, and Kellanova announced that they have entered into a definitive agreement under which Mars has agreed to acquire Kellanova for $83.50 per share in cash, for a total consideration of $35.9 billion, including assumed net leverage.1